Lipid-based carriers: manufacturing and applications for pulmonary route

Bibliography

• Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007;25:563-70
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Kuno Y, Sugimoto S, Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 2005;102:373-81
   PubMed Web of Science ®Google Scholar
• Suarez S, Hickey AJ. Drug properties affecting aerosol behavior. Respir Care 2000;45:652-66
   PubMedGoogle Scholar
• Zeng X, Martin G, Marriott C. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drag delivery system. Eur J Pharm Sci 1995;3:87-93
   Web of Science ®Google Scholar
• Schreier H, Gonzalez-Rothib R, Stecenko A. Pulmonary delivery of liposomes. J Control Release 1993;24:209-23
   Web of Science ®Google Scholar
• Twigg HL. Pulmonary host defenses. J Thorac Imaging 1998;13:221-33
   PubMed Web of Science ®Google Scholar
• Nicod LP. Pulmonary defence mechanisms. Respiration 1999;66:2-11
   PubMed Web of Science ®Google Scholar
• Dailey LA, Schmehl T, Gessler T, Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. J Control Release 2003;86:131-44
   PubMed Web of Science ®Google Scholar
• Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst 2002;19:425-98
   PubMed Web of Science ®Google Scholar
• Taylor G, Kellaway I. Pulmonary drug delivery. In: Hillery A, Lloyd A, Swarbrick J, editors. Drug Delivery And Targeting. Taylor & Francis; New York: 2001. p. 269-300
   Google Scholar
• Newman SP. Aerosol deposition considerations in inhalation therapy. Chest 1985;88:152S-60S
   PubMed Web of Science ®Google Scholar
• Bangham A, Horne RW. Negative staining of phospholipids and their structural modification by surface active agents as observed in the electron microscope. J Mol Biol 1964;8:660-8
   PubMed Web of Science ®Google Scholar
• Parthasarathy R, Gilbert B, Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemother Pharmacol 1999;43:277-83
   PubMed Web of Science ®Google Scholar
• Sweeney LG, Wang Z, Loebenberg R, Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm 2005;305:180-5
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller GK. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis (Edinb) 2005a85:227-34
   PubMed Web of Science ®Google Scholar
• Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsul 1995;12:229-46
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med 1976;295:765-70
   PubMed Web of Science ®Google Scholar
• Fendler JH, Romero A. Liposomes as drug carriers. Life Sci 1977;20:1109-20
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma U. Liposomes in drug delivery: progress and limitations. Int J Pharm 1997;154:123-40
   Web of Science ®Google Scholar
• Eichler H, Senior J, Stadler A, Kinetics and disposition of fluorescein-labelled liposomes in healthy human subjects. Eur J Clin Pharmacol 1988;34:475-9
   PubMed Web of Science ®Google Scholar
• Thomas D, Myers M, Wichert B, Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. Chest 1991;99:1268-70
   PubMed Web of Science ®Google Scholar
• Waldrep JC, Gilbert BE, Knight CM, Pulmonary delivery of beclomethasone liposome aerosol in volunteers. tolerance and safety. Chest 1997;111:316-23
   PubMed Web of Science ®Google Scholar
• Lasic D, Papadjopoulos D. Liposomes revisited. Science 1995;267:1275-6
   PubMed Web of Science ®Google Scholar
• Kim S, Turker MS, Chi EY, Preparation of multivesicular liposomes. Biochim Biophys Acta 1983;728:339-48
   PubMed Web of Science ®Google Scholar
• Szoka FJ, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978;75:4194-8
   PubMed Web of Science ®Google Scholar
• Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett 2005;10:711-19
   PubMed Web of Science ®Google Scholar
• Meure LA, Foster NR, Dehghani F. Conventional and dense gas techniques for the production of liposomes: a review. AAPS PharmSciTech 2008;9:798-809
   PubMed Web of Science ®Google Scholar
• Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004;7:252-9
   PubMed Web of Science ®Google Scholar
• Deamer D, Bangham AD. Large volume liposomes by an ether vaporization method. Biochim Biophys Acta 1976;443:629-34
   PubMed Web of Science ®Google Scholar
• Schieren H, Rudolph S, Finkelstein M, Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses. Biochim Biophys Acta 1978;542:137-53
   PubMed Web of Science ®Google Scholar
• Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973;298:1015-19
   PubMed Web of Science ®Google Scholar
• Pons M, Foradada M, Estelrich J. Liposomes obtained by the ethanol injection method. Int J Pharm 1993;95:51-6
   Web of Science ®Google Scholar
• Luna EJ, McConnell HM. The intermediate monoclinic phase of phosphatidylcholines. Biochim Biophys Acta 1977;466:381-92
   PubMed Web of Science ®Google Scholar
• Lasic DD. A molecular model for vesicle formation. Biochim Biophys Acta 1982;692:501-2
   PubMed Web of Science ®Google Scholar
• Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch Biochem Biophys 1981;212:186-94
   PubMed Web of Science ®Google Scholar
• Li C, Deng Y. A novel method for the preparation of liposomes: freeze drying of monophase solutions. J Pharm Sci 2004;93:1403-14
   PubMed Web of Science ®Google Scholar
• Cui J, Li C, Deng Y, Freeze-drying of liposomes using tertiary butyl alcohol/water cosolvent systems. Int J Pharm 2006;312:131-6
   PubMed Web of Science ®Google Scholar
• Wang T, Deng Y, Geng Y, Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim Biophys Acta 2006;1758:222-31
   PubMed Web of Science ®Google Scholar
• Mozafari MR, Reed CJ, Rostron C, Formation and characterisation of non-toxic anionic liposomes for delivery of therapeutic agents to the pulmonary airways. Cell Mol Biol Lett 2002;a7:243-4
   PubMed Web of Science ®Google Scholar
• Mozafari MR, Reed CJ, Rostron C, Construction of stable anionic liposome-plasmid particles using the heating method: a preliminary investigation. Cell Mol Biol Lett 2002b7:923-7
   PubMed Web of Science ®Google Scholar
• Wagner A, Vorauer-Uhl K, Kreismayr G, The crossflow injection technique: an improvement of the ethanol injection method. J Liposome Res 2002a12:259-70
   PubMed Web of Science ®Google Scholar
• Wagner A, Vorauer-Uhl K, Kreismayr G, Enhanced protein loading into liposomes by the multiple crossflow injection technique. J Liposome Res 2002b12:271-83
   PubMed Web of Science ®Google Scholar
• Wagner A, Platzgummer M, Kreismayr G, GMP production of liposomes-a new industrial approach. J Liposome Res 2006;16:311-19
   PubMed Web of Science ®Google Scholar
• Jahn A, Vreeland WN, Gaitan M, Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. J Am Chem Soc 2004;126:2674-5
   PubMed Web of Science ®Google Scholar
• Jahn A, Reiner J, Vreeland W, Preparation of nanoparticles by continuous-flow microfluidics. J Nanopart Res 2008;10:925-34
   Web of Science ®Google Scholar
• Jahn A, Vreeland WN, DeVoe DL, Microfluidic directed formation of liposomes of controlled size. Langmuir 2007;23:6289-93
   PubMed Web of Science ®Google Scholar
• Jaafar-Maalej C, Charcosset C, Fessi H. A new method for liposome preparation using a membrane contactor. J Lipid Res 2011;21:213-20
   Web of Science ®Google Scholar
• Charcosset C. Membrane processes in biotechnology: an overview. Biotechnol Adv 2006;24:482-92
   PubMed Web of Science ®Google Scholar
• Laouini A, Jaafar-Maalej C, Sfar S, Liposome preparation using a hollow fiber membrane contactor-application to spironolactone encapsulation. Int J Pharm 2011;415:53-61
   PubMed Web of Science ®Google Scholar
• Castor TP. Phospholipid nanosomes. Curr Drug Deliv 2005;2:329-40
   PubMedGoogle Scholar
• Frederiksen L, Anton K, van Hoogevest P, Preparation of liposomes encapsulating water-soluble compounds using supercritical carbon dioxide. J Pharm Sci 1997;86:921-8
   PubMed Web of Science ®Google Scholar
• Otake K, Imura T, Sakai H, Development of a new preparation method of liposomes using supercritical carbon dioxide. Langmuir 2001;17:3898-901
   Web of Science ®Google Scholar
• Otake K, Shimomura T, Goto T, Preparation of liposomes using an improved supercritical reverse phase evaporation method. Langmuir 2006;22:2543-50
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96
   PubMed Web of Science ®Google Scholar
• Almeida A, Runge S, Muller R. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 1997;149:255-65
   Web of Science ®Google Scholar
• Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm 2002;241:341-4
   PubMed Web of Science ®Google Scholar
• Muller RH, Maassen S, Weyhers H, Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 1996;4:161-70
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003;257:153-60
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781-5
   PubMed Web of Science ®Google Scholar
• Gasco M. Method for producing solid lipid microspheres having a narrow size distribution. 1993; USP 5.250.236
   Google Scholar
• Hu F, Jiang S, Du Y, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 2005;45:167-73
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Tamayo-Esquivel D, Ganem-Quintanar A, Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci 2005;26:211-18
   PubMed Web of Science ®Google Scholar
• Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles–evaluation of the method and process parameters. Eur J Pharm Biopharm 2003;55:125-31
   PubMed Web of Science ®Google Scholar
• Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 2005;108:112-20
   PubMed Web of Science ®Google Scholar
• Chattopadhyay P, Shekunov BY, Yim D, Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007;59:444-53
   PubMed Web of Science ®Google Scholar
• Gershkovich P, Wasan KM, Barta CA. A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery. Crit Rev Ther Drug Carrier Syst 2008;25:545-84
   PubMed Web of Science ®Google Scholar
• Sawant KK, Dodiya SS. Recent advances and patents on solid lipid nanoparticles. Recent Pat Drug Deliv Formul 2008;2:120-35
   PubMedGoogle Scholar
• Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004;56:1527-35
   PubMed Web of Science ®Google Scholar
• Muller RH, Runge S, Ravelli V, Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm 2006;317:82-9
   PubMed Web of Science ®Google Scholar
• Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine 2007;2:289-300
   PubMed Web of Science ®Google Scholar
• Videira MA, Botelho MF, Santos AC, Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 2002;10:607-13
   PubMed Web of Science ®Google Scholar
• Xiang Q, Wang M, Chen F, Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch Pharm Res 2007;30:519-25
   PubMed Web of Science ®Google Scholar
• Zhang P, Tu Y, Wang S, Preparation and characterization of budesonide­loaded solid lipid nanoparticles for pulmonary delivery. J Chin Pharm Sci 2011;20:390-6
   Google Scholar
• Abdelbary G, Fahmy R. Diazepam-Loaded Solid Lipid Nanoparticles: design and Characterization. AAPS Pharm Sci Tec 2009;10:211-19
   PubMed Web of Science ®Google Scholar
• Videira M, Almeida AJ, Fabra A. Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomedicine 2011; in Press
   Web of Science ®Google Scholar
• Yu W, Liu C, Liu Y, Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 2010;27:1584-96
   PubMed Web of Science ®Google Scholar
• Taylor K, Taylor G, Kellaway I, The stability of liposomes to nebulisation. Int J Pharm 1990;58:57-61
   Web of Science ®Google Scholar
• Misra A, Jinturkar K, Patel D, Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opin Drug Deliv 2009;6:71-89
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Solid Lipid Nanoparticles as insulin inhalation carriers for enhanced pulmonary deliver. J Biomed Nanotechnol 2009;5:84-92
   PubMed Web of Science ®Google Scholar
• Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 2009;29:196-212
   PubMed Web of Science ®Google Scholar
• Knight V, Koshkina N, Waldrep C, Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice. Trans Am Clin Climatol Assoc 2000;111:135-45
   PubMedGoogle Scholar
• Koshkina NV, Kleinerman ES, Waidrep C, 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res 2000;6:2876-80
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing B, Wu J, Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. Pulm Pharmacol Ther 2008;21:239-46
   PubMed Web of Science ®Google Scholar
• Verschraegen CF, Gilbert BE, Loyer E, Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 2004;10:2319-26
   PubMed Web of Science ®Google Scholar
• Koshkina NV, Waldrep JC, Roberts LE, Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 2001;7:3258-62
   PubMed Web of Science ®Google Scholar
• Trammer B, Amann A, Haltner-Ukomadu E, Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo. Eur J Pharm Biopharm 2008;70:758-64
   PubMed Web of Science ®Google Scholar
• Behr J, Zimmermann G, Baumgartner R, Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation. J Aerosol Med Pulm Drug Deliv 2009;22:121-30
   PubMed Web of Science ®Google Scholar
• Ruijgrok EJ, Vulto AG, Van Etten EW. Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats. J Pharm Pharmacol 2000;52:619-27
   PubMed Web of Science ®Google Scholar
• Vyas SP, Quraishi S, Gupta S, Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm 2005;296:12-25
   PubMed Web of Science ®Google Scholar
• Vyas SP, Kannan ME, Jain S, Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 2004;269:37-49
   PubMed Web of Science ®Google Scholar
• Zaru M, Mourtas S, Klepetsanis P, Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 2007;67:655-66
   PubMed Web of Science ®Google Scholar
• Zaru M, Manca M, Fadda AM, Chitosan-coated liposomes for delivery to lungs by nebulisation. Colloids Surf B Biointerfaces 2009;71:88-95
   PubMed Web of Science ®Google Scholar
• Zaru M, Sinico C, De Logu A, Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation. J Liposome Res 2009;19:68-76
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Y, Wurtz W, Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size. J Aerosol Med Pulm Drug Deliv 2008;21:245-54
   PubMed Web of Science ®Google Scholar
• Weers J, Metzheiser B, Taylor G, A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv 2009;22:131-8
   PubMed Web of Science ®Google Scholar
• Joshi M, Misra AN. Pulmonary disposition of budesonide from liposomal dry powder inhaler. Methods Find Exp Clin Pharmacol 2001;23:531-6
   PubMed Web of Science ®Google Scholar
• Konduri KS, Nandedkar S, Duzgunes N, Efficacy of liposomal budesonide in experimental asthma. J Allergy Clin Immunol 2003;111:321-7
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang C. Pulmonary delivery of insulin by liposomal carriers. J Control Release 2006;113:9-14
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J Drug Target 2008;16:639-48
   PubMed Web of Science ®Google Scholar
• Chimote G, Banerjee R. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis. J Biomed Mater Res B Appl Biomater 2010;94:1-10
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb) 2005b85:415-20
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Fu H, Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008;356:333-44
   PubMed Web of Science ®Google Scholar
• Hu L, Jia Y, WenDing Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery. Pharmazie 2010;65:585-7
   PubMed Web of Science ®Google Scholar
• Ghaffari S, Varshosaz J, Saadat A, Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomedicine 2011;6:35-43
   Web of Science ®Google Scholar